Product
GPC3 and/or TGFβ targeting CAR-T cells
1 clinical trial
6 indications
Indication
Hepatocellular CarcinomaIndication
ImmunotherapyIndication
CARIndication
GPC3 Gene InactivationIndication
T cellIndication
Lung CancerClinical trial
CAR-T Cell Targeting GPC3 for Immunotherapy of Hepatocellular Carcinoma: Phase I Clinical TrialStatus: Recruiting, Estimated PCD: 2025-08-01